Vasodilatory effects of cholecystokinin: New role for an old peptide?

Regulatory Peptides

Volumn 137, Issue 3, 2006, Pages 179-184

  Ruiz Gayo, Mariano ^a   González, M Carmen ^b   Fernández Alfonso, Soledad ^c  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Cerebral blood flow; Cholecystokinin; Migraine; Nitric oxide; Panic attack; Postprandial blood flow; Splanchnic blood flow

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; NEUROPEPTIDE; NITRIC OXIDE; PEPTIDE;

ARTERY; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; ENZYME RELEASE; HUMAN; HYPEREMIA; MESENTERIC ARTERY; MIGRAINE; NONHUMAN; PANIC; PATHOPHYSIOLOGY; POSTPRANDIAL STATE; PRESYNAPTIC NERVE; PRIORITY JOURNAL; REVIEW; SPLANCHNIC BLOOD FLOW; VASODILATATION;

ANIMALS; BLOOD VESSELS; CEREBROVASCULAR CIRCULATION; CHOLECYSTOKININ; HUMANS; MIGRAINE DISORDERS; MODELS, CARDIOVASCULAR; NITRIC OXIDE; PANIC DISORDER; RECEPTORS, CHOLECYSTOKININ; SPLANCHNIC CIRCULATION; VASODILATION;

EID: 33751536307     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2006.06.006     Document Type: Review

References (69)

1. Crawley J.N., and Corwin R.L. Biological actions of cholecystokinin. Peptides 15 (1994) 731-755
2. Rehfeld J.F., and Hansen H.F. Characterization of preprocholecystokinin products in the porcine cerebral cortex. J Biol Chem 261 (1986) 5832-5840
3. Noble F., Wank S.A., Crawley J.N., Bradwejn J., Seroogy K.B., Hamon M., and Roques B.P. International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacol Rev 51 (1999) 745-781
4. Bunting M.W., Beart P.M., and Widdop R.E. Effects of the CCK(A) receptor antagonists SR-27,897B and PD 140548 on baroreflex function in conscious rats. Eur J Pharmacol 337 (1997) 35-39
5. Verberne A.J., and Sartor D.M. CCK-induced inhibition of presympathetic vasomotor neurons: dependence on subdiafragmatic vagal afferents and central NMDA receptors in the rat. Am J Physiol Regul Integr Comp Physiol 287 (2004) R809-R816
6. Friedrich A.E., and Gebhart G.F. Effects of spinal cholecystokinin receptor antagonists on morphine antinociception in a model of visceral pain in the rat. J Pharmacol Exp Ther 292 (2000) 538-544
7. Javanmard M., Shlik J., Kennedy S.H., Vaccarino F.J., Houle S., and Bradwejn J. Neuroanatomic correlates of CCK-4-induced panic attacks in healthy humans: a comparison of two time points. Biol Psychiatry 45 (1999) 872-882
8. Kellner M., Wiedmann K., Yassaouridis A., Levengood R., Song Guo L., Holsboer F., and Yehuda R. Behavioural and endocrine response to cholecystokinin tetrapeptide in patients with posttraumatic stress disorder. Biol Psychiatry 47 (2000) 107-111
9. 2 receptors: new implications for the pathophysiology of panic. J Cereb Blood Flow Metab 23 (2003) 364-370
10. Sánchez-Fernández C., González C., Beart P.M., Mercer L.D., Ruiz-Gayo M., and Fernández-Alfonso M.S. A novel role for cholecystokinin: regulation of mesenteric vascular resistance. Regul Pept 121 (2004) 145-153
11. Larsson L.I. Innervation of the pancreas by substance P, enkephalins, vasoactive intestinal polypeptide and gastrin/CCK immunoreactive nerves. J Histochem Cytochem 27 (1979) 1283-1284
12. Larsson L.I., and Rehfeld J.F. Localization and molecular heterogeneity of cholecystokinin in the central and peripheral nervous system. Brain Res 165 (1979) 201-218
13. Adegathe E. Distribution of calcitonin-gene related peptide, neuropeptides Y, vasoactive intestinal polypeptide, cholecystokinin-8, substance P and islet peptides in the pancreas of normal and diabetic rats. Neuropeptides 33 (1999) 227-235
14. Adegathe E., and Pallot D.J. Innervation of the pancreas of the one-humped camel by neuropeptide Y, galanin, calcitonin-gene related-peptide, atrial natriuretic peptide and cholecystokinin. Neuropeptides 30 (1996) 420-424
15. Doss D.N., Mekhail N.A., and Ekladdios E.Y. The localization of cholecystokinin immunoreactivity in the rat ovary and uterine tube. Neuropeptides 18 (1991) 87-91
16. Hendry S.H., Jones E.G., and Beinfeld M.C. Neurons in rat and monkey cerebral cortex make symmetric and have intimate associations with blood vessels. Proc Natl Acad Sci 80 (1983) 2400-2404
17. Liu-Chen L.-Y., Norregaard T.V., and Moskowitz M.A. Some cholecystokinin-8 immunoreactive fibres in large pial arteries originate from trigeminal ganglion. Brain Res 359 (1985) 166-176
18. O ́Connor T.P., and Van Der Kooy D. Enrichment of a vasoactive neuropeptide (calcitonin gene related peptide) in the trigeminal sensory projection to the intracranial arteries. J Neurosci 8 (1988) 2468-2476
19. Mercer L.D., Nunan J., Jones N.M., Lawrence A.J., Cheung N.S., Mercer J.F.B., Firth S.D., Thompson P., Jarrot B., Finkelstein D.I., and Beart P.M. Immunohistochemistry with antibodies to the cholecystokinin-A receptor reveals a widespread distribution in rat and monkey central nervous system. In: Geppetti P. (Ed). Peptidergic G protein-coupled receptors from basic research to clinical applications (1999), IOS Press 175-180
20. Chou C.C., Hsieh C.P., and Danney J.M. Comparison of vascular effects of gastrointestinal hormones in various organs. Am J Physiol 232 (1977) H103-H109
21. Sieber C., Beglinger C., Jaeger K., Hildebrand G., and Stalder G.A. Regulation of postprandial mesenteric blood flow in humans: evidence for a cholinergic nervous reflex. Gut 32 (1991) 361-366
22. Fara J.W., Rubinstein E.H., and Sonnenschein R.R. Mesenteric vasodilatation in response to intraduodenal fat. Physiologist 12 (1969) 219
23. Premen A.J., Kvietys P.R., and Granger D.N. Postprandial regulation of intestinal blood flow: role of gastrointestinal hormones. Am J Physiol 249 (1985) G250-G255
24. Thulin L. Effects of C-terminal octapeptide of cholecystokinin on splanchnic circulation in the dog. Acta Chir Scand 139 (1973) 687-690
25. Thulin L., and Olsson P. Effects of pure natural cholecystokinin on dog splanchnic circulation in the dog. Acta Chir Scand 139 (1973) 681-686
26. Fara J.W., and Madden K.S. Effect of secretin and cholecystokinin on small intestinal blood flow distribution. Am J Physiol 229 (1975) 1365-1370
27. Miura S., Tashiro H., Kurose I., Suematsu M., Serizawa H., Sekizuka E., Nagata H., Yoshioka M., and Tsuchiya M. Intestinal microcirculatory changes during fat absorption and the effect of cholecystokinin inhibitor. Am J Physiol 262 (1992) G399-G404
28. Stewart W.F., Linet M.S., and Celentano D.D. Migraine headaches and panic attacks. Psychosom Med 51 (1989) 559-569
29. Maton P.N., Selden A.C., and Chadwick V.S. Large and small forms of cholecystokinin in human plasma: measurement using high pressure liquid chromatography and radioimmunoassay. Regul Pept 4 (1982) 251-260
30. Maton P.N., Selden A.C., Fitzpatrick M.L., and Chadwick V.S. Infusion of cholecystokinin octapeptide in man: relation between plasma cholecystokinin concentrations and gallbladder emptying rates. Eur J Clin Invest 14 (1984) 37-41
31. Rehfeld J.F. Accurate measurement of cholecystokinin in plasma. Clin Chem 44 (1998) 990-1001
32. Rehfeld J.F. Neuronal cholecystokinin: one or multiple transmitters?. J Neurochem 44 (1985) 1-10
33. Doi R., Hosotani R., Inoue K., Kogire M., Sumi S., Fujii N., Yajima H., Rayford P.L., and Tobe T. Effect of synthetic cholecystikinin-33 on pancreatic blood flow in dogs. Pancreas 5 (1990) 615-620
34. Nakajima M., Naruse S., Kitagawa M., Ishiguro H., Jin C., Ito O., and Hayakawa T. Role of cholecystokinin in the intestinal phase of pancreatic circulation in dogs. Am J Physiol 280 (2001) G614-G620
35. Varga G., Papp M., Harsing L.G., Toth I.E., Gaal G., Somogyi G.T., and Vizi E.S. Neuroeffector transmission of the hepatic and pancreatico-duodenal isolated arteries of the dog. Gastroenterology 87 (1984) 1056-1063
36. Iwase M., Uchizono Y., Nakamura U., Nohara S., and Iida M. Effect of exogenous cholecystokinin on islet blood flow in anesthetized rats. Regul Pept 116 (2003) 87-93
37. Patel A.G., Toyama M.T., Nguyen T.N., Cohen G.A., Ignarro L.J., Reber H.A., and Ashley S.W. Role of nitric oxide in the relationship of pancreatic blood flow and exocrine secretion in cats. Gastroenterology 108 (1995) 1215-1220
38. West S.D., Helmer K.S., Chang L.K., Cui Y., Greeley G.H., and Mercer D.W. Cholecystokinin secretagogue-induced gastroprotection: role of nitric oxide and blood flow. Am J Physiol 284 (2003) G399-G410
39. Heinemann A., Jocic M., Peskar B.M., and Holzer P. CCK-evoked hyperemia in rat mucosa involves neural mechanisms and nitric oxide. Am J Physiol 270 (1996) G253-G258
40. A receptors. Br J Pharmacol 102 (1991) 119-122
41. Brzozowski T., Konturek P.C., Konturek S.J., Pajdo R., Drozdowicz D., Kwiecien S., and Hahn E.G. Acceleration of ulcer healing by cholecystokinin (CCK): role of CCK-A receptors, somatostatin, nitric oxide and sensory nerves. Regul Pept 82 (1999) 19-23
42. B receptors of the CCK-evoked hyperaemia in rat gastric mucosa. Br J Pharmacol 116 (1995) 2274-2278
43. Reiman E.M., Raichle M.E., Butler F.K., Herscovitch P., and Robins E. A focal brain abnormality in panic disorder, a severe form of anxiety. Nature 310 (1984) 683-685
44. Reiman E.M., Raichle M.E., Robins E., Mintun M.A., Fusselman M.J., Fox P.T., Price J.L., and Hackman K.A. Neuroanatomical correlates of a lactate-induced anxiety attack. Arch Gen Psychiatry 46 (1989 a) 493-500
45. Reiman E.M., Fusselman M.J., Fox P.T., and Raichle M.E. Neuroanatomical correlates of anticipatory anxiety. Science 243 (1989 b) 1071-1074
46. Nutt D., and Lawson C. Panic attacks. A neurochemical overview of models and mechanisms. Br J Psychiatry 160 (1992) 165-178
47. 2 challenge of patients with panic disorder. Am J Psychiatry 144 (1987) 1080-1082
48. 2 vulnerability in panic disorder. Psychiatry Res 20 (1987) 87-95
49. Bradwejn J., Koszycki D., and Meterissian G. Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder. Can J Psychiatry 35 (1990) 83-85
50. Bradwejjn J., Koszycki D., and Shriqu C. Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings. Arch Gen Psychiatry 48 (1991) 603-610
51. Bradwejjn J., Koszycki D., Annable L., Couetoux Du Tertre A., Reines S., and Karkanias C. A dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorder. Biol Psychiatry 32 (1992) 903-912
52. Benkelfat C., Bradwejn J., Meyer E., Ellembogen M., Milot S., Gjedde A., and Evans A. Functional neuroanatomy of CCK-4-induced anxiety in normal healthy volunteers. Am J Psychiatry 152 (1995) 1180-1184
53. Bradwejn J., Koszycki D., Couëtoux Du Tertre A., Van Mengen H., Den Boer J., and Westenberg H. The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder. Arch Gen Psychiatry 51 (1994) 486-493
54. Bradwejn J., Koszycki D., Paradis M., Reece P., Hinton J., and Sedman A. Effect for CI-988 on cholecystokinin tetrapeptide-induced panic symptoms in healthy volunteers. Biol Psychiatry 38 (1995) 742-746
55. Bradwejn J., and Koszycki D. Cholecystokinin and panic disorder: past and future clinical research strategies. Scand J Clin Lab Invest 234 (2001) 19-27
56. Hosing V.G., Schirmacher A., Kuhlenbaumer G., Freitag C., Sand P., Schlesiger C., Jacob C., Fritze J., Franke P., Rietschel M., Garritsen H., Nothen M.M., Fimmers R., Stogbauer F., and Deckert J. Cholecystokinin- and cholecystokinin-B-receptor gene polymorphism in panic disorder. J Neural Transm 68 (2004) 147-156
57. Kennedy J.L., Bradwejn J., Koszycki D., King N., Crowe R., Vincent J., and Fourié O. Investigation of cholecystokinin system genes in panic disorder. Mol Psychiatry 4 (1999) 284-285
58. Breslau N., Schultz L.R., Stewart W.F., Lipton R., and Welch K.M. Headache types and panic disorder: directionality and specificity. Neurology 56 (2001) 350-354
59. Stewart W.F., Breslau N., and Keck P.E.J.R. Comorbidity of migraine and panic disorder. Neurology 44 (1994) S23-S27
60. Silberstein S.D. Shared mechanisms and comorbidities in neurologic and psychiatric disorders. Headache 41 (2001) S11-S17
61. Torelli P., and D'amico D. An updated review of migraine and co-morbid psychiatric disorders. Neurol Sci 25 (2004) S234-S235
62. Ossipova V.V., Kolosova O.A., and Vein A.M. Migraine associated with panic attacks. Cephalgia 19 (1999) 728-731
63. Marazziti D., Toni C., Pedri S., Bonucelli U., Pavese N., Nuti A., Muratorio A., Cassano G.B., and Akiskal H.S. Headache, panic disorder and depression: comorbidity or a spectrum?. Neuropsychobiology 31 (1995) 125-129
64. Marazziti D., Toni C., Pedri S., Bonucelli U., Pavese N., Lucetti C., Nuti A., Muratorio A., and Cassano G.B. Prevalence of headache syndromes in panic disorder. Int Clin Psychopharmacol 14 (1999) 247-251
65. Breslau N., and Davis G.C. Migraine, major depression and panic disorder: a prospective epidemiologic study of young adults. Cephalgia 12 (1992) 85-90
66. Waeber C., and Moskowitz M.A. Migraine as an inflammatory disorder. Neurology 64 (2005) S9-S15
67. Bolay H., Reuter U., Dunn A.K., Huang Z., Boas D.A., and Moskowit M.A. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 8 (2002) 136-142
68. Moskowitz M.A., Buzzi M.G., Sakas D.E., and Linnik M.D. Pain mechanisms underlying vascular headaches. Rev Neurol 145 (1989) 181-193
69. Hamel E. Perivascular nerves and the regulation of cerebral tone. J Appl Physiol 100 (2005) 1059-1064